Salvage vs Adjuvant Therapy in High-Risk Prostate Cancer
Dr. Matthew Mossanen interviews Adam Stuart Kibel MD on Salvage vs Adjuvant Therapy in High-Risk Prostate Cancer.
Video originally published on PracticeUpdate.com on 3/16/2020 -- https://www.practiceupdate.com/content/salvage-vs-adjuvant-therapy-in-high-risk-prostate-cancer/96396/45/1/3
--
Follow PracticeUpdate:
Twitter: https://twitter.com/practiceupdate
Facebook: https://www.facebook.com/practiceupdate
Instagram: https://www.instagram.com/practiceupdate_elsevier
LinkedIn: https://www.linkedin.com/showcase/practiceupdate
Register for PracticeUpdate for free at https://www.practiceupdate.com/welcome
Видео Salvage vs Adjuvant Therapy in High-Risk Prostate Cancer канала PracticeUpdate
Video originally published on PracticeUpdate.com on 3/16/2020 -- https://www.practiceupdate.com/content/salvage-vs-adjuvant-therapy-in-high-risk-prostate-cancer/96396/45/1/3
--
Follow PracticeUpdate:
Twitter: https://twitter.com/practiceupdate
Facebook: https://www.facebook.com/practiceupdate
Instagram: https://www.instagram.com/practiceupdate_elsevier
LinkedIn: https://www.linkedin.com/showcase/practiceupdate
Register for PracticeUpdate for free at https://www.practiceupdate.com/welcome
Видео Salvage vs Adjuvant Therapy in High-Risk Prostate Cancer канала PracticeUpdate
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
The Immune Landscape of Residual TNBC After Neoadjuvant ChemotherapyHeroin/Opioid Addiction Among Cancer Patients – Recommendations for PatientsCancer Related AnemiaA Review of Immunotherapy and Targeted Therapy in GlioblastomaNew Concepts in Metastatic Prostate CancerErlotinib Plus Ramucirumab for EGFR Mutant Lung CancerPractice Implications of Real World Data on First-Line Pazopanib in mRCCMetastatic Breast Cancer: Triple NegativePCI versus medical therapy for patients with symptomatic coronary artery disease?Interview on Multiple Myeloma TrialsGene Therapy for Advanced Parkinson’s DiseaseNew Data on Pancreatic Cancer from ASCO GISchizophrenia: Acute vs Chronic ManagementAdjuvant T-DM1 for Stage I HER2+ Breast CancerDepression Management: First-Line TreatmentsJAK2 and PD-L1 in 9p24 Amplified Breast CancerADA 2018: Observations from the DEVOTE trialImmunotherapy in the Management of Metastatic Triple Negative Breast CancerMitoxantrone and Veliparib in Prostate Cancer: Updates from ASCO 2017Use of Colony-Stimulating Factors Among Patients Receiving Intermediate-Risk Chemotherapies